Common use of Additional Permitted Disclosures Clause in Contracts

Additional Permitted Disclosures. Nothing in this Agreement (including without limitation in Sections 7.3, 11 or 12 of this Agreement) shall prevent Icagen or ▇▇▇▇▇▇: (i) in connection with efforts to secure financing, from issuing statements as to achievements made, and the status of the work being done by the parties pursuant to this Agreement so long as such statements do not jeopardize the ability to obtain patent protection on Program Inventions or Joint Program Inventions or entail disclosure of non-public technical or scientific Information; or (ii) from issuing statements or otherwise making disclosures that ▇▇▇▇▇▇ or Icagen determines, as applicable, to be necessary to comply with applicable law (including disclosure requirements of the U.S. Securities and Exchange Commission, NASDAQ or any other stock exchange on which securities issued by Icagen or ▇▇▇▇▇▇, as applicable, are traded); provided that to the extent practicable under the circumstances, such party shall provide the other party with a copy of the proposed text of such statements or disclosure sufficiently in advance of the scheduled release or publication thereof to afford such other party a reasonable opportunity to review and comment upon the proposed text.

Appears in 3 contracts

Sources: Research and License Agreement (Icagen Inc), Research and License Agreement (Icagen Inc), Research and License Agreement (Icagen Inc)